Ascendis Pharma
This talent pool in Austria is designed to help organizations identify and connect with potential candidates across various industries and roles. It serves as a resource for talent acquisition and workforce planning in the region.
Headquarters
Hellerup, Hovedstaden, Denmark
Company Size
501-1000 employees
Founded
2007
Ascendis Pharma is a biopharmaceutical company dedicated to developing innovative therapies for patients with rare endocrine diseases and cancer. Utilizing its proprietary TransCon technology platform, the company aims to create a fully integrated biopharma entity that improves patient care and outcomes. With a focus on science and patient needs, Ascendis Pharma is committed to making a meaningful difference for patients, caregivers, and healthcare professionals worldwide.
Ascendis Pharma A/S $ASND Shares Bought by Atika Capital Management LLC
8 hours ago
Ascendis Pharma grants 22,480 employee warrants at $240.52 per share
17 hours ago
Assessing Ascendis Pharma (NasdaqGS:ASND) Valuation After FDA Accelerated Approval Of YUVIWEL
2 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ascendis Pharma.
Pfizer Posts Cancer Data, Ascendis Wins FDA Approval and More
2 days ago